Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

XLRN

Acceleron Pharma (XLRN)

Acceleron Pharma Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:XLRN
FechaHoraFuenteTítuloSímboloCompañía
22/02/201706:00Business WireAcceleron Pharma to Webcast Conference Call of Fourth Quarter and Year Ended 2016 Financial Results on March 1, 2017NASDAQ:XLRNAcceleron Pharma Inc
14/02/201709:44Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:XLRNAcceleron Pharma Inc
01/02/201706:00Business WireAcceleron to Participate in Two Healthcare Investor Conferences in FebruaryNASDAQ:XLRNAcceleron Pharma Inc
09/01/201710:36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XLRNAcceleron Pharma Inc
06/01/201716:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
06/01/201706:00Business WireAcceleron Outlines Corporate Goals and Priorities for 2017NASDAQ:XLRNAcceleron Pharma Inc
04/01/201706:00Business WireAcceleron to Webcast Presentation at 35th Annual J.P. Morgan Healthcare ConferenceNASDAQ:XLRNAcceleron Pharma Inc
22/12/201616:00Business WireAcceleron Announces First Patient Treated in Phase 2 Trial of ACE-083 in Facioscapulohumeral Muscular DystrophyNASDAQ:XLRNAcceleron Pharma Inc
05/12/201616:45Business WireAcceleron & Celgene Announce Updated Results from Phase 2 Studies of Luspatercept in Beta-Thalassemia Presented at the 58th A...NASDAQ:XLRNAcceleron Pharma Inc
05/12/201615:10Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:XLRNAcceleron Pharma Inc
05/12/201606:00Business WireAcceleron & Celgene Announce Preliminary Results from an Investigator Initiated Phase 2 Study of Sotatercept in Myelofibrosis...NASDAQ:XLRNAcceleron Pharma Inc
04/12/201611:00Business WireAcceleron & Celgene Announce Updated Results from Ongoing Phase 2 Studies of Luspatercept in Myelodysplastic Syndromes at the...NASDAQ:XLRNAcceleron Pharma Inc
30/11/201606:00Business WireAcceleron Pharma to Host Conference Call & Webcast to Review Data Presented at the 58th American Society of Hematology Annual...NASDAQ:XLRNAcceleron Pharma Inc
03/11/201615:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XLRNAcceleron Pharma Inc
03/11/201615:05Business WireAcceleron Pharma Reports Third Quarter 2016 Financial and Operational ResultsNASDAQ:XLRNAcceleron Pharma Inc
03/11/201608:15Business WireAcceleron Announces New Data Presentations at the 58th American Society of Hematology Annual Meeting and ExpositionNASDAQ:XLRNAcceleron Pharma Inc
02/11/201606:00Business WireAcceleron to Present at Credit Suisse Healthcare Conference Monday, November 7, 2016NASDAQ:XLRNAcceleron Pharma Inc
27/10/201606:00Business WireAcceleron Pharma to Webcast Conference Call of Third Quarter 2016 Financial Results on November 3, 2016NASDAQ:XLRNAcceleron Pharma Inc
13/10/201606:00Business WireAcceleron to Host Educational Webcast on Facioscapulohumeral Muscular Dystrophy (FSHD) with Leading Researcher & Provide Over...NASDAQ:XLRNAcceleron Pharma Inc
27/09/201615:01Business WireAcceleron Announces Retirement of John Knopf as President and CEO; Habib Dable Named as SuccessorNASDAQ:XLRNAcceleron Pharma Inc
31/08/201606:00Business WireAcceleron to Participate in Three Healthcare Investor Conferences in SeptemberNASDAQ:XLRNAcceleron Pharma Inc
08/08/201614:50Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:XLRNAcceleron Pharma Inc
04/08/201606:00Business WireAcceleron Pharma Reports Second Quarter 2016 Financial and Operational ResultsNASDAQ:XLRNAcceleron Pharma Inc
28/07/201606:00Business WireAcceleron Pharma to Webcast Conference Call of Second Quarter 2016 Financial Results on August 4, 2016NASDAQ:XLRNAcceleron Pharma Inc
25/07/201615:05Business WireAcceleron Pharma Appoints Thomas McCourt to its Board of DirectorsNASDAQ:XLRNAcceleron Pharma Inc
08/07/201606:00Business WireAcceleron Announces ACE-083 Phase 1 Results at the 14th International Congress on Neuromuscular DiseasesNASDAQ:XLRNAcceleron Pharma Inc
29/06/201606:00Business WireAcceleron Announces Presentation of ACE-083 Phase 1 Healthy Volunteer Data at the 14th International Congress on Neuromuscula...NASDAQ:XLRNAcceleron Pharma Inc
10/06/201606:00Business WireAcceleron & Celgene Announce Updated Results from an Ongoing Phase 2 Study of Luspatercept in Beta-Thalassemia Presented at t...NASDAQ:XLRNAcceleron Pharma Inc
10/06/201606:00Business WireAcceleron & Celgene Announce Updated Results from an Ongoing Phase 2 Study of Luspatercept in Myelodysplastic Syndromes at th...NASDAQ:XLRNAcceleron Pharma Inc
07/06/201615:00Business WireAcceleron Pharma to Host Conference Call & Webcast to Review Updated Luspatercept Results Presented at the 21st Congress of t...NASDAQ:XLRNAcceleron Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:XLRN

Su Consulta Reciente

Delayed Upgrade Clock